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Phosphatidylethanol Reliably and Objectively Quantifies
Alcohol Consumption in Adolescents and Young Adults
Milan R€ohricht , Kerstin Paschke, Peter-Michael Sack, WolfgangWeinmann, Rainer
Thomasius, and Friedrich Martin Wurst
Background: Alcohol contributes to numerous annual deaths and various societal problems not just
in adult, but also in adolescent, populations. Therefore, it is vital to find methods for reliably detecting
alcohol use for early preventative measures. Research has shown phosphatidylethanol (PEth) to be
superior to self-report instruments and indirect biomarkers for alcohol consumption in adult popula-
tions. However, the transferability onto an adolescent population has not yet been investigated.
Methods: N = 106 adolescents and young adults aged between 13 and 21 years were included. PEth
analysis using high-pressure liquid chromatography–tandem mass spectrometry was performed on
dried blood spot samples. Self-report questionnaires for alcohol consumption (Alcohol Use Disorders
Identification Test—Consumption, AUDIT-C, and Timeline Followback, TLFB) and drug and alco-
hol consumption (Detection of Alcohol and Drug Problems in Adolescents, DEP-ADO) were com-
pleted by each participant.
Results: AUDIT-C scores showed large correlations with PEth 16:0/18:1 (rs = 0.732) and PEth
16:0/18:2 (rs = 0.661) concentrations. AUDIT-C with a cutoff value ≥3 was largely correlated with
PEth 16:0/18:1 (g = 0.411) and showed a medium-sized correlation with PEth 16:0/18:2 (g = 0.397)
concentrations. Using an AUDIT-C cutoff value ≥5 showed large correlations with both PEth 16:0/
18:1 (g = 0.510) and PEth 16:0/18:2 (g = 0.497) concentrations, respectively. ROC curves indicated
higher PEth concentrations are a good model for detecting positive AUDIT-C cutoff values (AUROC
range: 0.800 to 0.849). PEth concentrations showed medium to large correlations with DEP-ADO and
TLFB subscales (range rs = 0.469 to 0.746).
Conclusion: The results suggest that PEth is a reliable and objective marker for quantifying alcohol
consumption in adolescents and young adults. This could be of importance for early preventative mea-
sures against hazardous alcohol consumption, which is increasingly common at younger ages.
Key Words: Alcohol Use Disorders Identification Test—Consumption, Ethyl Glucuronide,
Phosphatidylethanol, Self-Reported Alcohol Consumption.
ALCOHOL IS ONE of the most widely used addictivesubstances worldwide: In 2018, 43% of the population
aged 15 years and older reported consumption in the past
12 months. Specifically for younger populations, 27% of 15-
to 19-year-olds worldwide reported to be current drinkers
(World Health Organization; WHO, 2018). Between 2000
and 2014, the rates of acute alcohol poisoning requiring hos-
pitalization in Germany have increased for 10- to 19-year-
olds by 162 and 120% for females and males, respectively
(despite a small decline between 2012 and 2014; Rabenberg
et al., 2016). Since alcohol abuse contributes to the develop-
ment of a vast spectrum of illnesses and societal problems
(Karriker-Jaffe et al., 2018; Laslett et al., 2010), it is impor-
tant to find methods whereby hazardous alcohol use can be
reliably detected, thus allowing for early preventative mea-
sures.
Recent findings suggest that direct biomarkers of alcohol
consumption—in particular phosphatidylethanol (PEth) and
ethyl glucuronide (EtG)—are superior to the indirect
biomarkers c-glutamyl transferase, carbohydrate-deficient
transferrin, and mean corpuscular volume (for a comparison
of direct versus indirect biomarkers, see, for example, Isaks-
son et al., 2011; Mann et al., 2016; Wurst et al., 2015).
PEth is an abnormal phospholipid, consisting of a glycerol
backbone with fatty acid chains at positions sn-1 and sn-2,
and phosphoethanol via an ester bond at position sn-3. It is
only synthesized in the presence of alcohol in a reaction with
phosphatidylcholine, catalyzed by the phospholipase D, even
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when only minimal amounts of ethanol (EtOH) are present
in the blood (Alling et al., 1983; Gnann et al., 2010; Gustavs-
son and Alling, 1987; Lundqvist et al., 1994). Currently,
there are 48 known homologues of PEth; the 2 most com-
mon homologues of PEth are 16:0/18:1 and 16:0/18:2
(Gnann et al., 2010). As a biomarker for alcohol consump-
tion, PEth has a half-life of 4 to 10 days (Varga et al., 2000;
Weinmann et al., 2016). As a result of this variance, a precise
time frame for PEth quantifiability in the blood is difficult to
predict, but estimations range from 3 to 12 days after a single
drinking event (Schr€ock et al., 2017a) and 9 to 10 days
(Schr€ock et al., 2014) to 21 to 29 days (Gnann et al., 2010;
Wurst et al., 2015) after prolonged use. Various studies have
also shown a positive correlation between the amount of
alcohol consumed and the blood PEth concentration in
adults (Hartmann et al., 2006; Wurst et al., 2010).
A second direct biomarker, EtG, is a metabolite of EtOH
formed through the activity of the enzyme UDP-glucurono-
syltransferase (Wurst et al., 2015). Only minimal amounts of
EtOH (1 g) need to be consumed to render a measurable
EtG value (Wurst et al., 2015). EtG is detectable in blood for
around 36 hours; in urine for around 5 days (if only a small
amount, i.e., <1 g EtOH is consumed, this is reduced to 11 to
27 hours); and in hair for 3 to 6 months (Thon et al., 2013;
Wurst et al., 2015). In contrast to PEth, a retrospective deter-
mination of alcohol consumption patterns is feasible using
EtG in hair, but only to a limited extent in blood and urine
(Wurst et al., 2015).
Recent research also suggests these direct biomarkers to
be superior to self-report instruments, such as the Alcohol
Use Disorder Identification Test (AUDIT) and Timeline
Followback (TLFB), for precise quantification of alcohol
consumption (for self-reporting vs. direct biomarkers, see,
for example, Hahn et al., 2012; Schr€ock et al., 2017b). Self-
report measures are subject to underreporting of alcohol
consumption in sample populations with a social desirability
bias. This has been reported for HIV-infected patients (Hahn
et al., 2012b). Underreporting also occurs in antenatal popu-
lations (May et al., 2018).
Notwithstanding certain limitations (see “Discussion” sec-
tion), the bulk of current research reiterates the recommen-
dation of the 2014 German evidence- and consensus-based
S3 guidelines for the use of PEth in blood and EtG in hair as
indicators for chronic alcohol consumption in adult popula-
tions (Mann et al., 2016, 2017).
However, the transferability of these findings onto an
adolescent population has not been investigated thus far.
Adolescents and young adults tend to show heavy episo-
dic patterns of alcohol consumption (Piano et al., 2017),
which may have an impact on PEth and EtG concentra-
tions. To the best of our knowledge, this is the first study
explicitly examining the correlation between direct
biomarkers (PEth and EtG) and self-reporting instru-
ments (Alcohol Use Disorders Identification Test—Con-
sumption [AUDIT-C] and TLFB) in a clinical adolescent
population.
Establishing PEth as a reliable and objective marker of
alcohol consumption in adolescents would be beneficial for
sensitive circumstances with a potential social desirability
bias, such as binge-drinking youths or those with a prior
criminal record (Richter and Johnson, 2001). PEth could
also be useful during alcohol withdrawal treatment and
relapse monitoring, as suggested for adult populations (Lug-
inb€uhl et al., 2019b). We hypothesize PEth to be a feasible
direct biomarker for these purposes.
Purpose of the Study
The primary goal of the present study was to investigate
the correlation between self-reported alcohol consumption,
using the AUDIT-C, and a direct biomarker for alcohol con-
sumption, PEth, in a clinical population of adolescents and
young adults.
Secondary goals were to investigate: (i) correlations
between PEth concentrations, TLFB scores, and results of a
brief assessment of at-risk alcohol and drug use in adoles-
cents, the DEP-ADO (Detection of Alcohol and Drug Prob-
lems in Adolescents), and (ii) correlations between EtG in
urine, AUDIT-C, DEP-ADO, and TLFB.
MATERIALS ANDMETHODS
Participants
One hundred and six adolescents and young adults between 13
and 21 years old were subsequently included in the present study.
The primary inclusion criterion was current treatment at the Ger-
man Center for Addiction Research in Childhood and Adolescence
of the Department of Child and Adolescent Psychiatry and Psy-
chotherapy at the University Medical Center Hamburg-Eppendorf
in Hamburg, Germany.
Exclusion criteria were as follows: (i) mental disability and (ii)
insufficient command of the German language. Lack of substance
abuse was not an exclusion criterion, nor was readmittance within
the recruitment period.
Study Design
In this cross-sectional, diagnostic study, inpatients from the
youth addiction ward and outpatients from the youth addiction
day-care ward and drug and alcohol treatment center at the Univer-
sity Medical Center Hamburg-Eppendorf were subsequently
included over a 7-month period from October 2018 until April
2019.
Participants on the youth addiction ward and youth addiction
day-care ward underwent routine venous blood collection on the
day of admittance or shortly after. PEth analysis was performed on
dried blood spot (DBS) samples to ensure PEth stability (Faller
et al., 2013; Schr€ock et al., 2016). DBS was generated using DBS
bioanalysis cards on the day of collection from lithium-heparinized
venous blood samples (v-DBS). After DBS generation according to
a standard operation procedure (Luginb€uhl et al., 2019b), the cards
were folded shut and placed in a ziplock bag along with a silica gel
drying agent. These were stored at20°C for a maximum of 8 days,
before being shipped at room temperature to the cooperating labo-
ratory (Institute of Forensic Medicine, University of Bern, Switzer-
land). All of the questionnaires were completed within 3 days of v-
DBS generation.
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For the participants from the drug and alcohol treatment center,
capillary blood was used and DBS was immediately generated (c-
DBS), prior to storage under the same conditions as the v-DBS and
shipment to the cooperating laboratory (Luginb€uhl et al., 2019b).
All of the questionnaires were completed on the same day as c-DBS
generation.
AUDIT-C, TLFB, DEP-ADO
In the short form of the AUDIT, the AUDIT-C, only the
first 3 items (focusing on alcohol consumption: quantity, fre-
quency, and binge drinking, i.e., ≥6 drinks on one occasion) are
used as a brief screening tool (Bush et al., 1998; German trans-
lation Babor et al., 2001). For means of comparison in the pre-
sent study, a “standard drink” was defined in accordance with
the guidelines suggested by the National Institute on Alcohol
Abuse and Alcoholism (Babor et al., 2001; Johnston et al.,
2011) as containing 14 g of pure EtOH, hence approximated as
330 ml beer (alcohol by volume approx. 5%), 150 ml wine (al-
cohol by volume approx. 12%), or 40 ml spirits (alcohol by vol-
ume approx. 40%). For male and female participants, the cutoff
value at which the screening is considered positive for heavy
drinking and/or active alcohol abuse or dependence (Bush et al.,
1998) has been suggested as 3 or higher (Liskola et al., 2018).
Elsewhere, slightly higher cutoff values of ≥4 and ≥5 (Schr€ock
et al., 2017b) or ≥5 and ≥7 (DeMartini and Carey, 2012) have
been suggested for females and males, respectively. Due to this
discrepancy in the literature, we conducted our analyses for 2
cutoff values separately, namely ≥3 and ≥5.
The TLFB is a calendar-based drinking assessment tool that
allows retrospective specifications on the amount and frequency
of alcohol consumption (Sobell et al., 1979). A modified version,
mirroring the consumption time frame detected by PEth, was
used for the present study. After the precise amount of alcohol
consumed during this period is determined (using the same
“standard drink” convention, see above), 3 questions focus on
whether the consumed amount reported for the past 7 days were
typical for the past month and year, respectively, and whether
the amount of alcohol consumed a year ago was approximately
the same as currently. If not, that is, if more or less alcohol was
consumed in the past 7 days than in the past month or year,
then a second (and third) score will be calculated for the total
amount consumed in the past month (TLFB-2) or year (TLFB-
3) as an average per week.
The DEP-ADO is a 7-question screening tool for detecting prob-
lematic alcohol or drug use (Germain et al., 2007; Landry et al.,
2016). Questions primarily address the frequency of substance use
in both the past 30 days and 12 months, and the age of initiation,
prior injection drug use, severity of drug use, and possible negative
effects associated with substance abuse. DEP-ADO-a, the first sub-
scale assessing alcohol consumption, is of particular interest for the
present study. The English version 3.2 was used in the present study,
translated into the German language according to standard prac-
tice.
The AUDIT-C has been validated for children and adolescents
(Liskola et al., 2018; Rumpf et al., 2013) and young adults (Bush
et al., 1998). Only the French version of the DEP-ADO has been
validated for ages 14 to 17 years (pertinent for use with 12- to 13-
year-olds; Germain et al., 2007). In the present study, it was also
used for slightly older participants because we expected the psycho-
logical developmental age of the study population to be lower than
the respective biological age, as a result of delayed maturation con-
tingent on emotional stress. The TLFB-modified version has not
been validated for a German population, but content validity can be
assumed by literature as it is often used as the gold standard (John-
son et al., 2013).
Determination of PEth and UEtG (EtG in Urine)
Whole blood concentrations of the 2 most common PEth homo-
logues, 16:0/18:1 and 16:0/18:2 (Gnann et al., 2010), were measured
using high-pressure liquid chromatography–tandem mass spectrom-
etry (HPLC-MS/MS; Luginb€uhl et al., 2019a) at the Institute of
Forensic Medicine, University of Bern, Switzerland.
For both PEth homologues, there was a discrepancy between the
level of detection (LOD) and level of quantification (LOQ; Ulwel-
ling and Smith, 2018), which was 6 and 20 µg/l, respectively. For
values between the LOD and LOQ, reported by the laboratory as
<20 µg/l, we estimated the median value, which was 13 µg/l.
EtG was quantified by immunoassay in urine (in mg/l), as a clini-
cal routine on the 2 wards and the treatment center, at the Depart-
ment of Legal Medicine at the University Medical Center
Hamburg-Eppendorf.
Statistics
Correlations were analyzed using Spearman’s rank correlation
coefficient (rs), as all variables were significantly nonnormal (tested
using the Kolmogorov–Smirnov test; K-S test, D). Further, eta cor-
relation (g) was used to assess the association between categorical
and metric variables, as was the case for AUDIT-C cutoff scores
compared with PEth and EtG concentrations. Spearman’s rs corre-
lation coefficients of 0.1, 0.3, and 0.5 are interpreted as small,
medium, and large, respectively (Cohen, 1992). Eta correlations of
0.1, 0.25, and 0.4 are interpreted as small, medium, and large,
respectively.
A theoretically desired level of statistical significance was defined
at a ≤ 0.05. For PEth 16:0/18:1 and PEth 16:0/18:2 concentrations,
respectively, a maximum of k = 8 independent significance tests
were conducted. After the Bonferroni adjustment, an empirical
p ≤ 0.006 therefore indicates the desired 5% level. For UEtG con-
centrations and k = 10 significance tests, this would hold true given
an empirical p ≤ 0.005.
Receiver operating characteristic (ROC) curves were plotted for
PEth 16:0/18:1 and 16:0/18:2 concentrations against AUDIT-C cut-
off values. An area under the ROC curve (AUROC) of 0.6, 0.7, 0.8,
and 0.9 is interpreted as of weak or poor, moderate or fair, good,
and excellent statistical property, respectively (Carter et al., 2016;
Greiner et al., 2000). For better comparability, sensitivity and speci-
ficity values are reported in tables, but as usual 1–specificity values
are given in diagrams.
All statistical analysis was performed using SPSS Statistics (ver-
sion 25, IBM Corp., https://www.ibm.com/de-de/products/spss-sta
tistics).
Ethics
The study was approved by the ethics committee of Hamburg’s
Chamber of Physicians (Ethik-Kommission der €Arztekammer Ham-
burg) on 16.07.2018 (file number PV5809). Further, an amendment
was approved on 28.01.2019. Informed, written consent was
obtained from each participant (and for those under 18 years old
additionally from a parent, carer, or legal guardian) prior to their
inclusion in the study.
RESULTS
Sample Characteristics
The sample consisted of N = 106 participants with a mean
age of 17.15 years (SD 1.47). More than 3 quarters of the
sample (77%) belonged to the adolescent age range between
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14 and 17. One third (35%) was female. On average, the par-
ticipants had received 9 full years of preuniversity education
prior to hospital admittance and study participation. Table 1
reports the detailed sample characteristics and patient demo-
graphics.
All test variables (PEth, AUDIT-C, DEP-ADO, TLFB,
and UEtG) showed a skewed distribution; hence, nonpara-
metric correlational measures were used and medians (with
interquartile range) reported. As shown in Table 2, correla-
tions between these measures were significant (all p-val-
ues < 0.001), at least medium-sized and predominantly large.
In summary, PEth concentrations showed high concordance
with self-reported alcohol consumption, in particular with
AUDIT-C, TLFB, andDEP-ADO alcohol subscale scores.
Correlation Between AUDIT-C and PEth Concentrations
Correlation analysis with Spearman’s rank showed large
correlations between AUDIT-C scores and PEth 16:0/18:1
(rs = 0.732) and PEth 16:0/18:2 (rs = 0.661) concentrations,
respectively (details given in Table 2, Figs 1 and 2).
Comparison of DEP-ADO and PEth Concentrations
Also reported in detail in Table 2, the DEP-ADO alcohol
subscale and total score were investigated with regard to
PEth. The alcohol subscale largely correlated (rs = 0.668
and 0.620), and the total score showed a large or medium
correlation (rs = 0.536 and 0.469) with PEth 16:0/18:1 and
PEth 16:0/18:2 concentrations, respectively.
Comparison of TLFB and PEth Concentrations
As shown in Table 2, Spearman’s rank showed large cor-
relations between PEth homologues and all TLFB subscales:
for TLFB-1 (rs = 0.730 and rs = 0.746), TLFB-2 (rs = 0.732
and rs = 0.704), and TLFB-3 (rs = 0.742 and rs = 0.685)
with PEth 16:0/18:1 and PEth 16:0/18:2 concentrations,
respectively.
Exploratory Analysis With UEtG
Correlation analysis with Spearman’s rank showed large
correlations between UEtG and PEth 16:0/18:1 (rs = 0.594)
and PEth 16:0/18:2 (rs = 0.602) concentrations, as well as
between UEtG and TLFB-1 and TLFB-2 scores (rs = 0.639
and rs = 0.531, respectively, Table 3).
Further, medium correlations were found between UEtG
concentrations and AUDIT-C scores (rs = 0.483), DEP-
ADO alcohol subscale scores (rs = 0.466), and TLFB-3
scores (rs = 0.487).
ROC Analysis for AUDIT-C and PEth
To evaluate PEth concentrations with regard to a binary
screening cutoff value, in this case AUDIT-C scores, we ana-
lyzed area under receiver operating characteristic curve
(AUROC; see Table 4), sensitivity, and specificity for cutoff
values ≥3 and ≥5 with respect to increasing PEth
Table 1. Sample Characteristics (N = 106)
M (SD) or Mdn (IQR)/n
(%)a
Age in yearsb 17.15 (SD 1.47)
Child (<14 years) 3 (2.8%)
Adolescents (14 to 17 years) 82 (77.4%)
Young adults (≥18 years) 21 (19.8%)
Sex (male/female) 69 (65.1%)/37 (34.9%)
DBSmethod
v-DBS 74 (69.8%)
c-DBS 32 (30.2%)
Years of preuniversity education (n = 102) 9.10 (SD 1.18)
ICD-10 diagnosesc
F0 (Organic, including symptomatic) 0 (0.0%)
F1 (Psychoactive substance-related
disorder)
75 (70.7%)
F10 (Alcohol) 30 (28.3%)
F11 (Opioid) 13 (12.3%)
F12 (Cannabinoids) 64 (60.4%)
F13 (Sedatives or hypnotics) 10 (9.4%)
F14 (Cocaine) 21 (19.8%)
F15 (Other stimulants) 22 (20.8%)
F16 (Hallucinogens) 7 (6.6%)
F17 (Tobacco) 51 (48.1%)
F18 (Volatile solvents/inhalants) 0 (0.0%)
F19 (Multiple drug use/other) 3 (2.8%)
F2 (Schizophrenia, schizotypal) 4 (3.7%)
F3 (Mood, affective) 69 (65.1%)
F4 (Neurotic, stress-related, somatoform) 34 (32.1%)
F5 (Behavioral syndromes) 3 (2.8%)
F6 (Personality) 34 (32.0%)
F7 (Mental retardation) 0 (0.0%)
F8 (Psychological development) 5 (4.7%)
F9 (Onset in childhood/ adolescence) 85 (80.2%)
AUDIT-C (n = 101) 4 (IQR 6)
Negative (<3 points) 37 (36.6%)
Positive (≥3 points) 64 (63.4%)
Negative (<5 points) 56 (55.4%)
Positive (≥5 points) 45 (44.6%)
DEP-ADO (n = 100) 21 (IQR 26)
Green light (no obvious problem) 38 (38.0%)
Yellow light (developing problem) 9 (9.0%)
Red light (obvious problem) 53 (53.0%)
TLFB (n = 101) in g EtOH
TLFB-1 (last week) 0 (IQR 52.4)
TLFB-2 (average per week in last month) 19.8 (IQR 79.6)
TLFB-3 (average per week in last year) 26.4 (IQR 99.4)
PEth (n = 102) in µg/l
PEth 16:0/18:1 13 (IQR 36)
Not detected (<6 µg/l) 48 (47.1%)
PEth 16:0/18:2 6.5 (IQR 27)
Not detected (<6 µg/l) 51 (50.0%)
UEtG (n = 79) in mg/l 4 (IQR 6)
AUDIT/-C, Alcohol Use Disorders Identification Test—Consumption; c-
DBS/v-DBS, capillary/venous dried blood spot; DEP-ADO, Detection of
Alcohol and Drug Problems in Adolescents; ICD-10, International Statisti-
cal Classification of Diseases and Related Health Problems—Version 10;
PEth, phosphatidylethanol in blood; TLFB, Timeline Followback; UEtG,
ethyl glucuronide in urine.
aData are means (M) with standard deviations (SD), medians (Mdn) with
interquartile ranges (IQR) or frequencies (n) with percentages (%)
bAge groups according to the Protection of Young Persons Act in Ger-
many (JuSchG §1.1)
cNames given in short form for orientation purposes only.
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concentrations (see Table 5, Figs 3 and 4). ROC curves show
both PEth 16:0/18:1 and PEth 16:0/18:2 concentrations to be
a good model for detecting positive AUDIT-C cutoff values
(AUROC: 0.800 to 0.849 and 0.806 to 0.845, respectively),
with no superiority of one of these. But according to Table 5
results—using cutoff values generated by the statistic
Fig. 1. Scatter diagram for PEth 16:0/18:1 concentrations and AUDIT-C scores (N = 100). [Color figure can be viewed at wileyonlinelibrary.com]
Fig. 2. Scatter diagram for PEth 16:0/18:2 concentrations and AUDIT-C scores (N = 100). [Color figure can be viewed at wileyonlinelibrary.com]
Table 2. Spearman Rank Correlations (rs) Between PEth 16:0/18:1 and PEth 16:0/18:2 Concentrations (in µg/l) and Self-Report Instruments*
AUDIT-C AUDIT-C (≥3)a AUDIT-C (≥5)a DEP-ADO DEP-ADO-a TLFB-1 TLFB-2 TLFB-3
PEth 16:0/18:1 0.732
n = 100
0.411
n = 100
0.510
n = 100
0.536
n = 99
0.668
n = 99
0.730
n = 100
0.732
n = 100
0.742
n = 100
PEth 16:0/18:2 0.661
n = 100
0.397
n = 100
0.497
n = 100
0.469
n = 99
0.620
n = 99
0.746
n = 100
0.704
n = 100
0.685
n = 100
AUDIT/-C, Alcohol Use Disorders Identification Test—Consumption (≥3/≥ 5): respective cutoff value; DEP-ADO, Detection of Alcohol and Drug Prob-
lems in Adolescents—a, alcohol subscale; PEth, phosphatidylethanol in blood; TLFB, Timeline Followback:1, 2, 3: last week, last month, last year,
respectively.
aEta correlation (g).
*All p-values < 0.001 indicating statistical significance at 5% level after the Bonferroni adjustment.
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program which followed the empirical data distribution—
both PEth concentrations revealed better predictions of the
AUDIT-C cutoff value ≥5.
DISCUSSION
The purpose of this study was to investigate the correla-
tion between self-reported alcohol consumption and the
direct biomarker PEth in a population of adolescents and
young adults. Our main findings were as follows:
1. a strong correlation between self-reported and PEth-
quantified alcohol consumption,
2. higher PEth concentrations to be a good model for detect-
ing positive screening results, that is, AUDIT-C cutoff
values ≥3 or ≥5 (AUROC range: 0.800 to 0.849), and
3. moderate correlation between self-reported and UEtG-
quantified alcohol consumption.
This is in general accordance with recent research on PEth
in adult populations and supports our hypothesis, suggesting
the feasibility of using PEth as an objective and valid alcohol
consumption marker in adolescents.
As a direct biomarker of alcohol consumption, PEth
seems to have certain advantages over indirect biomarkers
and self-report instruments: Indirect biomarkers may be con-
tingent upon non–alcohol-related factors, while accuracy of
self-reporting instruments has shown to decline in situations
with social desirability for lower consumption patterns
(Hahn et al., 2012b; Richter and Johnson, 2001)—although
as Figs 1 and 2 show, underreporting alcohol consumption
in the AUDIT-C was not a significant concern in the present
study. There are also limitations associated with PEth. As
previous studies have discussed, these include a possible
influence of nutrition, in vitro neoformation, blood alcohol
concentration (BAC), and interindividual variation in phos-
pholipase activity on PEth concentrations (e.g., Schr€ock
et al., 2017a; Weinmann et al., 2016). Further research is
required to investigate the confounding influence of such fac-
tors, which are as yet merely hypothetical (preliminary data
is available for the impact of BAC, see Schr€ock et al., 2018).
More specific to the present study, an important difference
between measures is the consumption time frame they quan-
tify: PEth is detectable in blood for around 2 to 3 weeks
(Schr€ock et al., 2017a; Wurst et al., 2015), while EtG is
detectable in urine for around 5 days (Thon et al., 2013;
Wurst et al., 2015), although both are dependent on the
amount of alcohol consumed (see Introduction). Among the
self-report instruments, the TLFB quantifies consumption
for the past 7 days, 30 days, and 12 months; likewise, the
DEP-ADO quantifies consumption for the past 30 days and
Table 4. AUROC (n = 100) for PEth Homologues and AUDIT-C Cutoff
Values*
AUDIT-C cutoff ≥3 AUDIT-C cutoff ≥5
PEth 16:0/18:1
AUROC 0.849 0.845
95% CI 0.773 to 0.924 0.765 to 0.926
PEth 16:0/18:2
AUROC 0.800 0.806
95% CI 0.715 to 0.885 0.715 to 0.896
AUROC, area under receiver operating characteristic curve; AUDIT/-C,
Alcohol Use Disorders Identification Test—Consumption; CI, confidence
interval; PEth, phosphatidylethanol in blood (in µg/l); ROC, receiver operat-
ing characteristic.
*All p-values < 0.001.
Table 5. ROCCurve (n = 100) Sensitivity and Specificity for PEth
Homologue Concentrations at AUDIT-C Cutoff Values ≥3/≥5
Cutoff (in
µg/l)
AUDIT-C cutoff ≥3 AUDIT-C cutoff ≥5
Sensitivity Specificity Sensitivity Specificity
PEth 16:0/
18:1
6.5 0.762 0.892 0.841 0.732
16.5 0.492 0.973 0.614 0.911
20.5 0.476 0.973 0.591 0.911
24.0 0.444 0.973 0.545 0.911
28.5 0.444 1 0.545 0.929
31.5 0.429 1 0.545 0.946
PEth 16:0/
18:2
6.5 0.698 0.838 0.773 0.714
16.5 0.460 0.973 0.568 0.911
20.5 0.444 0.973 0.545 0.911
22.5 0.429 0.973 0.545 0.929
25.0 0.397 0.973 0.523 0.946
31.5 0.365 1 0.477 0.964
AUDIT/-C, Alcohol Use Disorders Identification Test—Consumption;
PEth, phosphatidylethanol in blood; ROC, receiver operating characteris-
tic.
Table 3. Spearman Rank Correlations (rs) Between UEtG Concentrations (in mg/l), PEth 16:0/18:1 and PEth 16:0/18:2 Concentrations (in µg/l), and
Self-Report Instruments
PEth 16:0/
18:1
PEth 16:0/
18:2 AUDIT-C
AUDIT-C
(≥3)*
AUDIT-C
(≥5)* DEP-ADO
DEP-ADO-
a TLFB-1 TLFB-2 TLFB-3
UEtG 0.594
p < 0.001,
n = 79
0.602
p < 0.001,
n = 79
0.483
p < 0.001,
n = 77
0.241
p = 0.042,
n = 77
0.256
p = 0.023
n = 77
0.305
p = 0.063,
n = 76
0.466
p < 0.001,
n = 76
0.639
p < 0.001,
n = 77
0.531
p < 0.001,
n = 77
0.487
p < 0.001,
n = 77
AUDIT/-C, Alcohol Use Disorders Identification Test—Consumption (≥3/≥5): respective cutoff value; DEP-ADO, Detection of Alcohol and Drug Prob-
lems in Adolescents—a, alcohol subscale; PEth, phosphatidylethanol in blood; TLFB, Timeline Followback: 1,2,3, last week, last month, last year,
respectively; UEtG, ethyl glucuronide in urine
*Eta correlation (g) not statistically significant at 5% level after the Bonferroni adjustment.
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12 months, while the AUDIT-C only quantifies consump-
tion for the past 12 months.
Hence, although there is a certain overlap in detection time
frames between biomarker and self-report instruments, in
particular for consumption in the past 1 to 4 weeks detect-
able by PEth, UEtG, TLFB-1/-2, and DEP-ADO-a, there is
a discrepancy between others, notably PEth concentrations
and AUDIT-C scores. However, this discrepancy is not
unique to the present study and has been considered and
reported elsewhere: Across various studies, regardless of
whether the AUDIT-C time frame was adjusted to the past
month (Jain et al., 2014) or the past 3 months (Asiimwe
et al., 2015), maintained at 1 year (Schr€ock et al., 2017b) or
taking only reports of abstinence for the analysis (Eyawo
et al., 2017), correlations with PEth concentrations remained
fairly constant. The strength of correlations was further cor-
roborated by additional self-report instruments (other than
AUDIT-C) which quantified similar time frames to PEth in
the respective studies. It can consequently be assumed that in
adult populations, consumption patterns on the whole (ac-
counting for individual differences) can be considered to be
relatively stable, that is, a consumption pattern reported over
a period of 1 to 3 months is unlikely to change significantly
over the course of a year, hence the significant results com-
paring PEth concentrations and AUDIT-C scores.
Based on the results from the present study which show
large correlations between overlapping and nonoverlapping
time frames for biomarker and self-report instruments,
respectively, a similar deduction for adolescents can be made:
Although PEth is only quantifiable in blood for approxi-
mately 2 to 3 weeks, it appears to be a reliable indicator of
alcohol consumption within this time frame and beyond,
possibly as a result of reasonably stable consumption pat-
terns. Notably, this is in contrast to the anticipated limitation
of consumption patterns in an adolescent population inter-
rupted by many more days of abstinence, thus being of a
heavy, episodic rather than continuous nature. It would be
instructive for future research to assess interindividual con-
sumption patterns and to compare PEth results to this vari-
able. As an alternative conclusion, it is also plausible that
PEth concentrations are indeed stable across different con-
sumption patterns. This will need to be subject to further
research. Further, although PEth concentrations will not be
available immediately upon sampling, it would be instructive
to compare PEth levels with real-time BAC to investigate a
possible underreporting of longer-term alcohol consumption
during acute intoxication.
With respect to the AUDIT-C screening, our ROC analy-
sis results show that both PEth homologues are a good
model for detecting positive screening results, regardless of
whether AUDIT-C cutoff values of ≥3 or ≥5 were tested.
However, as the ≥3 cutoff leads to a large rate of false posi-
tives, overall the result for the ≥5 cutoff value is better and
should thus be preferred.
Inversely, however, based on our results it is difficult to
make accurate recommendations for an optimal PEth con-
centration cutoff value to predict a positive AUDIT-C
screening. The ROC curves indicate an optimal PEth
Fig. 3. ROC analysis for PEth homologues and AUDIT-C cutoff value ≥3. Source of the curve (printed in figure). [Color figure can be viewed at wileyon
linelibrary.com]
PETH IN ADOLESCENTS AND YOUNG ADULTS 2183
concentration of 6.5 µg/l. For PEth 16:0/18:1, this optimal
point has sensitivity of 84% and specificity of 73% for
AUDIT-C ≥ 5. Likewise, for PEth 16:0/18:2, optimal point
has sensitivity of 77% and specificity of 71% for ≥5 cutoff
value, respectively (see Table 5). As a PEth concentration of
6.5 µg/l lies between the LOD (6 µg/l) and LOQ (20 µg/l),
such a cutoff value would cease to be more than an approxi-
mation, not directly measurable.
Overall, the results for the ROC curves are promising, but
not final. Study replication, especially with participants with
clinical diagnoses, and employing other validation criteria,
would be advantageous. In particular, diagnoses could
become more reliable in populations prone to self-report
bias, such as young men with a prior criminal record (Richter
and Johnson, 2001). More reliable diagnoses would, in turn,
enable expedient therapeutic planning.
Limitations
In addition to the limitations associated with PEth yet to
be conclusively resolved, it cannot be excluded that the 2 dif-
ferent blood sampling methods, v-DBS and c-DBS, influ-
enced results. Further, the modified TLFB version and the
DEP-ADO German translation used in this study have only
content validity to date, and an intoxicated state during
study participation cannot be excluded for some partici-
pants, all of which may have influenced the self-reported
data.
CONCLUSIONS
In a population of adolescents and young adults, we found
PEth to be a reliable and objective biomarker for quantifying
alcohol consumption. Notwithstanding further research,
establishing PEth as a routine test could prove helpful in vari-
ous clinical settings: as a binary measure when any pattern of
alcohol consumption is considered harmful (e.g., during preg-
nancy or for critically ill patients); for a range of issues in legal
medicine, such as the allocation of transplant organs; in situa-
tions susceptible to social desirability bias where self-reporting
instruments are inherently unsuitable; and finally, as a tool for
contingency management aimed at reducing hazardous alco-
hol consumption, by using direct biomarkers such as PEth to
augment self-report measures (McDonell et al., 2017).
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